| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.002 |